A ferroptosis amplifier based on triple-enhanced lipid peroxides accumulation strategy for effective pancreatic cancer therapy
Authors:
- 21 April 2024
- journal article
- research article
- Published by Elsevier in Biomaterials
- Vol. 309, 122574
Abstract
No abstract availableKeywords
Funding Information
- Natural Science Foundation of Shanghai Municipality (23ZR1466700)
- National Natural Science Foundation of China (82160478, 81703075, 22277090, 22277090 81703075)
- Shanghai Municipal Health Commission (2022LJ012)
This publication has 38 references indexed in Scilit:
- Tumor microenvironment-initiated lipid redox cycling for efficient triple-negative breast cancer therapyBiomaterials, 2023
- Bioactive Iridium Nanoclusters with Glutathione Depletion Ability for Enhanced Sonodynamic‐Triggered Ferroptosis‐Like Cancer Cell DeathAdvanced Materials, 2022
- Evoking tumor associated macrophages by mitochondria-targeted magnetothermal immunogenic cell death for cancer immunotherapyBiomaterials, 2022
- Non-apoptotic cell death-based cancer therapy: Molecular mechanism, pharmacological modulators, and nanomedicineActa Pharmaceutica Sinica B, 2022
- Apoptosis-enhanced ferroptosis therapy of pancreatic carcinoma through PAMAM dendrimer-iron(III) complex-based plasmid deliveryScience China Chemistry, 2022
- Metal‐Polyphenol‐Network Coated Prussian Blue Nanoparticles for Synergistic Ferroptosis and Apoptosis via Triggered GPX4 Inhibition and Concurrent In Situ Bleomycin ToxificationSmall, 2021
- Cancer cells escape autophagy inhibition via NRF2-induced macropinocytosisCancer Cell, 2021
- Recent Progress in Ferroptosis Inducers for Cancer TherapyAdvanced Materials, 2019
- GPX4 at the Crossroads of Lipid Homeostasis and FerroptosisProteomics, 2019
- Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell DeathCell, 2012